According to the NACI website, this is “due to limited information on the efficacy of this vaccine in this age group at this time.”
However, the agency said the vaccine has “demonstrated an average efficacy of approximately 62 per cent in those aged 18-64 years of age.”
The vaccine received approval from Health Canada on Friday.
NACI said it should be delivered in two doses four to 12 weeks apart.
It became the third vaccine to receive regulatory approval in Canada, joining ones from Moderna and Pfizer-BioNTech.
Canada has ordered 24 million doses of the AstraZeneca vaccine.
-More to come..
© 2021 Global News, a division of Corus Entertainment Inc.